B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
about
Biomarkers in heart failure with preserved ejection fractionThe role of natriuretic peptides for the diagnosis of left ventricular dysfunctionHeart failure with preserved ejection fractionCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityINTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologistAssociation between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure.Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyBNP and Heart Failure: Preclinical and Clinical Trial Data.Interpretation and use of natriuretic peptides in non-congestive heart failure settingsNatriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failureMarked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fractionAdmission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.Multimarker approach for the prediction of heart failure incidence in the communityRelationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction.Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsEvolution of biomarker guided therapy for heart failure: current concepts and trial evidence.Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohortGalectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fractionB-type natriuretic peptide: a critical review.Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatmentFrom statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failureAssociation of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study.Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.(99m)Tc-MIBI Washout Rate to Evaluate the Effects of Steroid Therapy in Cardiac Sarcoidosis.The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findings.Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart FailureBiomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women.Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease.Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Evaluation of heart function with impedance cardiography in acute myocardial infarction patients.Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.Narrative review: the management of acute decompensated heart failure.
P2860
Q26768192-6AC8BB91-67C9-495D-B938-245716C03552Q26825665-364AEA0F-9CF0-41B1-B3CC-36BEB04BC0A8Q27024008-D2E7FBF0-3429-4EC4-830D-4A06FF6DD37DQ28081407-EA2A23CE-1CE0-4D9C-A739-AB6680A5D39CQ28083473-9878741B-397B-4158-9723-C0F03F78C2B8Q30404603-067B4051-5485-47F2-986E-8824410E85DFQ30483582-BE26B06A-6A3B-486D-9672-D80613D47C46Q30909922-FDF2C5B3-4EE8-4C6E-A33B-12D8C312B55FQ33670478-20BC1C14-678F-4BE6-91FD-62C0B432CE83Q33902623-03CD1A09-7388-4253-9A38-C9851BD87614Q33917736-F8C5270E-17CF-4900-804F-67D9676D93A9Q33956698-EBA07639-1690-4F2B-B246-86796A540F0DQ34357369-643E2288-C9F4-4801-81A4-AA0A4949CA21Q34434691-68AA87EB-B229-4DCD-A5E4-60FD11EFCCB1Q34623775-87B7BB6F-36A1-4E20-9B63-E416E5397D1DQ35139959-318852AA-A4B8-4F74-8514-E088E9F05F33Q35139977-F578EF6E-3CAC-4C71-B091-D2E754277B7FQ35151512-0405722C-944D-4254-8270-3120AF964D59Q35219570-1B7D6A4E-B5A7-4851-A10F-33E355E67437Q36035702-E26E6BB5-3D20-451D-824B-6D36A0AA6CB7Q36167458-9E69E877-3827-44D7-A6BA-B52BCD8B374CQ36171125-4087B267-B4BA-4095-98E6-69B46810D9CDQ36203267-38B78CDA-B8D3-4968-BB2F-347FAABC16ECQ36724549-EFB77333-19D8-424E-9787-3E606F44C811Q36760329-63512F2F-A0B0-450B-A1A6-268E3AC89430Q37029837-4F2D0F8C-24F1-4E87-81A2-A57FA7858C2DQ37038819-23F0BC2E-A588-4CC1-AEB8-8BD66CD893A7Q37038967-9267ABD1-609B-4D28-A5AE-64CFCC494ECCQ37052267-8DE17F9F-A4FD-44B2-8650-251AEAF7849CQ37232282-FB7298E0-EB07-4322-BFCB-B06E58AC0454Q37408637-64B19570-1ED1-44D5-8122-620D124E5C5CQ37414013-868533AE-E807-4AA2-AB0F-2C0DE129A9DFQ37419451-BA978C0D-572D-4F56-B18D-5667521AC87EQ37468738-A9ABE65A-2CBC-430B-9FC5-9EFD4432737CQ37554847-C2AFE447-7439-4494-BBC1-BC80CA1BF831Q37577757-49AE0442-1F7F-4FFF-AF69-B09FA065551FQ37681556-8B14138B-8B0A-4D37-AA3F-B169531C27B4Q37711483-F0407C8E-0C27-4E20-8070-403FB47FD234Q37725106-8751742A-F49E-4C5A-8CF6-EE5BBA27DA36Q37880500-6408C313-FB6C-44FB-A983-BFC5B73B6246
P2860
B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
B-type natriuretic peptide str ...... c and diastolic heart failure.
@en
B-type natriuretic peptide str ...... c and diastolic heart failure.
@nl
type
label
B-type natriuretic peptide str ...... c and diastolic heart failure.
@en
B-type natriuretic peptide str ...... c and diastolic heart failure.
@nl
prefLabel
B-type natriuretic peptide str ...... c and diastolic heart failure.
@en
B-type natriuretic peptide str ...... c and diastolic heart failure.
@nl
P2093
P921
P1476
B-type natriuretic peptide str ...... c and diastolic heart failure.
@en
P2093
Hiroshi Nonogi
Isao Nishi
Kazuhiro Sase
Shinichi Furuichi
Teruo Noguchi
Yasuki Kihara
Yoichi Goto
Yoshitaka Iwanaga
P304
P356
10.1016/J.JACC.2005.11.030
P407
P577
2006-01-26T00:00:00Z